Next report date
Report period
H1 2024
EPS estimate
−0.28HKD
Revenue estimate
265.30 MHKD
−1.47HKD
−826.31 MHKD
328.65 M
About CARSGEN THERAPEUTICS HLDGS LTD
Sector
CEO
Zong Hai Li
Headquarters
Shanghai
Website
Employees (FY)
516
Founded
2018
FIGI
BBG011BNS486
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2171 is 5.45 HKD — it has increased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CARSGEN THERAPEUTICS HLDGS LTD stocks are traded under the ticker 2171.
CARSGEN THERAPEUTICS HLDGS LTD is going to release the next earnings report on Aug 20, 2024. Keep track of upcoming events with our Earnings Calendar.
2171 stock is 4.81% volatile and has beta coefficient of 1.36. Check out the list of the most volatile stocks — is CARSGEN THERAPEUTICS HLDGS LTD there?
2171 earnings for the last quarter are −0.73 HKD per share, whereas the estimation was −0.50 HKD resulting in a −47.58% surprise. The estimated earnings for the next quarter are −0.97 HKD per share. See more details about CARSGEN THERAPEUTICS HLDGS LTD earnings.
Yes, you can track CARSGEN THERAPEUTICS HLDGS LTD financials in yearly and quarterly reports right on TradingView.
2171 stock has risen by 20.84% compared to the previous week, the month change is a 15.77% fall, over the last year CARSGEN THERAPEUTICS HLDGS LTD has showed a 56.12% decrease.
2171 net income for the last quarter is −370.90 M HKD, while the quarter before that showed −457.44 M HKD of net income which accounts for 18.92% change. Track more CARSGEN THERAPEUTICS HLDGS LTD financial stats to get the full picture.
Today CARSGEN THERAPEUTICS HLDGS LTD has the market capitalization of 3.14 B, it has decreased by 1.09% over the last week.
No, 2171 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2171 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARSGEN THERAPEUTICS HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 516.00 employees. See our rating of the largest employees — is CARSGEN THERAPEUTICS HLDGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARSGEN THERAPEUTICS HLDGS LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARSGEN THERAPEUTICS HLDGS LTD stock shows the sell signal. See more of CARSGEN THERAPEUTICS HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CARSGEN THERAPEUTICS HLDGS LTD future price: according to them, 2171 price has a max estimate of 8.60 HKD and a min estimate of 5.80 HKD. Read a more detailed CARSGEN THERAPEUTICS HLDGS LTD forecast: see what analysts think of CARSGEN THERAPEUTICS HLDGS LTD and suggest that you do with its stocks.